Top

International Journal of Clinical Pharmacy

Published in:

01-10-2010 | Conference Commentary

Implementing pharmacy practice research programs for the management of heart failure

Author: Michael D. Murray

Published in: International Journal of Clinical Pharmacy | Issue 5/2010

Abstract

It stands to reason that pharmacists would have a benefic role in the treatment of patients with chronic illnesses wherein complicated pharmacotherapies are required to reduce the risk of acute exacerbation. For chronic heart failure, recent evidence bears this out. When pharmacists take time to provide self-care instructions for patients with heart failure or take part in collaborative healthcare teams, the need for costly urgent healthcare decreases with corresponding decreases in healthcare costs. Further research is needed to address the key supportive roles of pharmacists in the treatment of patients with heart failure.

Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HGM. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: A randomized controlled study. J. Cardiac Failure. 2003;9(5):404–11.CrossRef

Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714–25.PubMed

Tsuyuki RT, Fradette M, Johnson JA, et al. A multicenter disease management program for hospitalized patients with heart failure. J. Cardiac Failure. 2004;10(6):473–80.CrossRef

Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: Long-term implications on readmission and survival. Circulation. 2002;105:2861–6.CrossRefPubMed

Stewart S, McAlister FA, McMurray JJ. Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med. 2005;165(11):1311; author reply 1311-1312.

Rodgers JE, Stough WG. Underutilization of evidence-based therapies in heart failure: the pharmacist’s role. Pharmacotherapy. 2007;27(4 Pt 2):18S–28S.CrossRefPubMed

Murray MD, Ritchey ME, Wu J, Tu W. Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular disease. Arch Intern Med. 2009;169(8):757–63.CrossRefPubMed

Bouvy ML, Heerdink ER, Leufkens HG, Hoes AW. Predicting mortality in patients with heart failure: a pragmatic approach. Heart. 2003;89(6):605–9.CrossRefPubMed

Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med. 1998;158(10):1108–12.CrossRefPubMed

10.

Murray MD, Tu W, Wu J, Morrow D, Smith F, Brater DC. Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther. 2009;85(6):651–8.CrossRefPubMed

Title: Implementing pharmacy practice research programs for the management of heart failure
Author: Michael D. Murray
Publication date: 01-10-2010
Publisher: Springer Netherlands
Published in: International Journal of Clinical Pharmacy / Issue 5/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI: https://doi.org/10.1007/s11096-010-9424-7

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Implementing pharmacy practice research programs for the management of heart failure

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2010

GPs’ views on patient drug use and the pharmacist’s role in DRP management

Challenges in chronic illness management: a qualitative study of Australian pharmacists’ perspectives

Over-the-counter sales of antibiotics from community pharmacies in Abu Dhabi

A novel method for signal detection of adverse drug reactions based on proportional reporting ratios

An evaluation of Australian pharmacist’s attitudes on expanding their prescribing role

Soon: a new year, a new name, a new face

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page